Tonix Pharmaceuticals Holding (TNXP) Goodwill & Intangibles (2015 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Goodwill & Intangibles came in at $120000.0 in Q1 2026, little changed year-on-year from $120000.0 in Q1 2025, and little changed quarter-over-quarter from $120000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Goodwill & Intangibles (2015 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Goodwill & Intangibles history runs 12 years deep, the most recent figure standing at $120000.0 for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles changed 0.0% year-over-year to $120000.0 in Q1 2026; TTM through Mar 2026 was $120000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $120000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles was little changed at $120000.0 in Q1 2026 per TNXP's latest filing, from $120000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $11.1 million in Q2 2023 and bottomed at $120000.0 in Q4 2022.
- The 5-year median for Goodwill & Intangibles is $120000.0 (2022), against an average of $3.4 million.
- Across the five-year window, Goodwill & Intangibles surged 8723.33% in 2023 and sank 98.92% in 2024, its largest moves.
- Year by year, Goodwill & Intangibles stood at $120000.0 in 2022, then jumped by 8723.33% to $10.6 million in 2023, then plunged by 98.87% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025, then changed by 0.0% to $120000.0 in 2026.
- Per Business Quant, the three latest TNXP Goodwill & Intangibles figures stand at $120000.0 (Q1 2026), $120000.0 (Q4 2025), and $120000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 10.35 Mn |
| Dec 31, 2023 | 10.59 Mn |
| Sep 30, 2023 | 10.95 Mn |
| Jun 30, 2023 | 11.07 Mn |
| Dec 31, 2022 | 120,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 120,000.00 |
| Jun 30, 2021 | 120,000.00 |
| Mar 31, 2021 | 120,000.00 |
| Dec 31, 2020 | 120,000.00 |
| Sep 30, 2020 | 120,000.00 |
| Jun 30, 2020 | 120,000.00 |